Phacilitate’s Investment for Advanced Therapies
May 03, 2017 in London, UK
Phacilitate’s Investment for Advanced Therapies meeting will be held on May the 3rd in London, UK.
David Sourdive, Ph.D., EVP of Technical Operations at Cellectis, to take part in this event from 11:55 AM to 12:25 PM during the "Industrialization of the cell and gene therapy industry" panel.